NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Xlife Sciences AG Shareholders Approve Annual Meeting Proposals
Xlife Sciences AG shareholders approved all proposals at the Annual General Meeting, with 54.3% of share capital represented. Key milestones include the Nasdaq listing of Veraxa Biotech and the planned Landsteiner Scientific platform to accelerate therapeutic development.
All proposals presented at the meeting were approved by shareholders.
3,134,367 voting shares, representing 54.3% of total share capital, were represented.
The Nasdaq listing of portfolio company Veraxa Biotech (NASDAQ: VRXA) and the planned Landsteiner Scientific platform were highlighted as key milestones supporting the next phase of growth.
The platform is intended to accelerate identification and development of novel therapeutic approaches and improve global market access for Xlife Sciences' portfolio companies.
It will integrate academic research with commercial development, serving as a cornerstone of the company's future innovation pipeline.
Xlife Sciences is a Swiss incubator and accelerator that develops and commercializes promising life sciences research projects from universities and research institutions.
Projects are selected in four areas: technological platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health.
The full press release is available at https://ibn.fm/nfUvM.
Visit www.xlifesciences.ch for more information.